CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c8a8d510-060f-4f04-a060-65d58ff2b225/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $4.2B | 2023-01-01 – 2023-12-31 | evidence 0001340122-24-000015 |
| FY 2022 | $4.7B | 2022-01-01 – 2022-12-31 | evidence 0001340122-24-000015 |
| FY 2021 | $3.1B | 2021-01-01 – 2021-12-31 | evidence 0001340122-22-000036 |
| FY 2020 | $2.3B | 2020-01-01 – 2020-12-31 | evidence 0001340122-21-000035 |
| FY 2019 | $3.5B | 2019-01-01 – 2019-12-31 | evidence 0001340122-20-000034 |
| FY 2018 | $3.5B | 2018-01-01 – 2018-12-31 | evidence 0001340122-19-000040 |
| FY 2017 | $3.8B | 2017-01-01 – 2017-12-31 | evidence 0001340122-19-000040 |
| FY 2016 | $3.5B | 2016-01-01 – 2016-12-31 | evidence 0001340122-19-000040 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. — all facts · Net Income · Operating Income